# Tirofiban for Successful Endovascular Stroke Thrombectomy

Study · id `cardio:ct-nct06373042` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06373042](<https://clinicaltrials.gov/study/NCT06373042>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06373042

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 712 participants.

## Technical summary

Registry record NCT06373042. Randomized; quadruple masking; primary purpose treatment. Start 2024-07-31 (anticipated); primary completion 2026-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 712 participants (planned count; ClinicalTrials.gov record NCT06373042, source copy `cardio:ctgov-nct06373042-2024-05-16`, retrieved 2026-11-18)
- Planned start: 2024-07-31 (anticipated) (ClinicalTrials.gov record NCT06373042, source copy `cardio:ctgov-nct06373042-2024-05-16`, retrieved 2026-11-18)
- Primary completion: 2026-07-31 (anticipated) (ClinicalTrials.gov record NCT06373042, source copy `cardio:ctgov-nct06373042-2024-05-16`, retrieved 2026-11-18)
- Completion: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT06373042, source copy `cardio:ctgov-nct06373042-2024-05-16`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06373042-2024-05-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: Tirofiban for Successful Endovascular Stroke Thrombectomy
- Acronym: ADJUVANT-2
- Condition: Stroke, Acute Ischemic
- Intervention (Drug): Intraarterial and intravenous tirofiban
- Intervention (Drug): Intraarterial and intravenous placebo
- Lead sponsor: Zhongming Qiu
- Lead sponsor class: OTHER
- Collaborator: Mianyang Central Hospital
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Chongqing Medical University
- Collaborator class: OTHER
- Collaborator: The Second Hospital of Jiaozuo
- Collaborator class: UNKNOWN
- Collaborator: Chongzhou People's Hospital
- Collaborator class: UNKNOWN
- Collaborator: Xihua First Hospital
- Collaborator class: OTHER
- Collaborator: Xingguo People's Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Mianyang Central Hospital (`cardio:org-mianyang-central-hospital`)
- Registry lists this organization as a collaborator: The Second Affiliated Hospital of Chongqing Medical University (`cardio:org-the-second-affiliated-hospital-of-chongqing-medical-739711`)
- Registry lists this organization as a collaborator: Xihua First Hospital (`cardio:org-xihua-first-hospital`)

## Provenance

Content hash: 61416cf821b8e8cefddbd94713f18efa8f441f7364e0277fe8a5c1b16cff3cea
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
